Your browser doesn't support javascript.
loading
Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020.
Mitra-Majumdar, Mayookha; Gunter, Simon J; Kesselheim, Aaron S; Brown, Beatrice L; Joyce, Krysten W; Ross, Murray; Pham, Catherine; Avorn, Jerry; Darrow, Jonathan J.
Afiliação
  • Mitra-Majumdar M; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Gunter SJ; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Kesselheim AS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Brown BL; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Joyce KW; Kaiser Permanente Institute for Health Policy, Oakland, California.
  • Ross M; Kaiser Permanente Institute for Health Policy, Oakland, California.
  • Pham C; Kaiser Permanente National Pharmacy, Downey, California.
  • Avorn J; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Darrow JJ; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
JAMA Netw Open ; 5(5): e2212454, 2022 05 02.
Article em En | MEDLINE | ID: mdl-35579897

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aprovação de Drogas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aprovação de Drogas Idioma: En Ano de publicação: 2022 Tipo de documento: Article